Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-408
Closed -$75K 146
2020
Q1
$75K Sell
408
-1,127
-73% -$201K 0.01% 162
2019
Q4
$256K Buy
+1,535
New +$228K 0.01% 172
2019
Q3
Sell
-3,193
Closed -$388K 315
2019
Q2
$388K Buy
3,193
+2,497
+359% +$296K 0.02% 376
2019
Q1
$80K Hold
696
﹤0.01% 448
2018
Q4
$80K Sell
696
-723
-51% -$85.2K ﹤0.01% 448
2018
Q3
$177K Sell
1,419
-323
-19% -$35.7K 0.01% 308
2018
Q2
$149K Buy
+1,742
New +$128K 0.02% 416
2017
Q1
Sell
-100
Closed -$4K 710
2016
Q4
$4K Buy
+100
New +$4.25K ﹤0.01% 384

Other funds holding AMED

Itau Unibanco Holding S.A.'s AMED Position: Q2 2020 in Review

Itau Unibanco Holding S.A. sold out of Amedisys (AMED) in Q2 2020, closing a stake of 408 shares — an estimated $75K sold.

Itau Unibanco Holding S.A. first reported a position in AMED in Q4 2016 and held it in 8 quarters. The position peaked at $388K in Q2 2019. 354 funds tracked by Wall St. Rank hold AMED as of Q2 2020.

  • Itau Unibanco Holding S.A. reported no remaining Amedisys position as of Q2 2020 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 408 Amedisys shares in Q2 2020, an estimated $75K.
  • Itau Unibanco Holding S.A. first reported a position in Amedisys in Q4 2016 and held it in 8 quarters.
  • Itau Unibanco Holding S.A.'s Amedisys position peaked at $388K in Q2 2019.
  • 354 funds tracked by Wall St. Rank held Amedisys as of Q2 2020.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2020, filed 14 Aug 2020.